Author:
Iwamoto Naoyuki,Inaba Yutaka,Kobayashi Naomi,Yukizawa Yohei,Ike Hiroyuki,Ishida Takashi,Saito Tomoyuki
Publisher
Springer Science and Business Media LLC
Subject
Endocrinology,Orthopedics and Sports Medicine,General Medicine,Endocrinology, Diabetes and Metabolism
Reference22 articles.
1. Arabmotlagh M, Rittmeister M, Hennigs T (2006) Alendronate prevents femoral periprosthetic bone loss following total hip arthroplasty: prospective randomized double-blind study. J Orthop Res 24:1336–1341
2. Boden HS, Skoldenberg OG, Salemyr MO, Lundberg HJ, Adolphson PY (2006) Continuous bone loss around a tapered uncemented femoral stem: a long-term evaluation with DEXA. Acta Orthop 77:877–885
3. Skoldenberg OG, Boden HS, Salemyr MO, Ahl TE, Adolphson PY (2006) Periprosthetic proximal bone loss after uncemented hip arthroplasty is related to stem size: DXA measurements in 138 patients followed for 2–7 years. Acta Orthop 77:386–992
4. Bobyn JD, Mortimer ES, Glassman AH, Engh CA, Miller JE, Brooks CE (1992) Producing and avoiding stress shielding. Laboratory and clinical observations of noncemented total hip arthroplasty. Clin Orthop Relat Res 274:79–96
5. Saleh KJ, Thongtrangan I, Schwarz EM (2004) Osteolysis: medical and surgical approaches. Clin Orthop Relat Res 427:138–147